"Onco-Immunotherapy, CRISPR, Cybernetic Implants, Regenerative Medicine, Gene Therapy, Robotics – many of these recent life sciences breakthroughs sound like science fiction.
"But they are very real. And the impact of discoveries such as these could redefine what it means to be human.
"Although these advancements are being realized through the most cutting-edge science, the greatest risk associated with marketing these products remains one of the oldest challenges.
Read more in "The 21st Century Cures Act Will Exacerbate Life Sciences Pharmaceutical Risk," from the Insights section of Risk & Insurance.